EQUITY

Clinical trials for EQUITY explained in plain language.

Never miss a new study

Get alerted when new EQUITY trials appear

Sign up with your email to follow new studies for EQUITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Long-acting HIV shot study aims to make prevention fairer for all

Disease control Not yet recruiting

This study looks at whether a long-acting injectable HIV prevention drug (cabotegravir) can be delivered fairly and effectively in NHS sexual health clinics. Researchers will follow 200 people taking the drug for 12 months, along with 20 healthcare professionals, to see how well …

Matched conditions: EQUITY

Sponsor: Queen Mary University of London • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

EQUITY

Get alerted when new EQUITY trials appear

Long-acting HIV shot study aims to make prevention fairer for all